Online First

July 10, 2020

Rheumatoid arthritis
Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection—a missing link for ACPA production

Madeleine Jenning, Bianka Marklein, Jimmy Ytterberg, Roman A Zubarev, Vijay Joshua, Dirkjan van Schaardenburg, Lotte van de Stadt, Anca Irinel Catrina, Ute Nonhoff, Thomas Häupl, Zoltán Konthur, Gerd R Burmester, Karl Skriner

doi: 10.1136/annrheumdis-2019-216919
Correspondence
‘Halo Score’: missing large-vessel giant cell arteritis— do we need a ‘modified Halo Score’?
Free

Arghya Chattopadhyay, Alakendu Ghosh

doi: 10.1136/annrheumdis-2020-218224
Correspondence response
Response to: ‘‘Halo Score’: missing large vessel giant cell arteritis– do we need a modified ‘Halo Score?’’ by Chattopadhyay and Ghosh
Free

Kornelis S M van der Geest, Bhaskar Dasgupta

doi: 10.1136/annrheumdis-2020-218262
Systemic lupus erythematosus
Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis

Kamala Vanarsa, Sanam Soomro, Ting Zhang, Briony Strachan, Claudia Pedroza, Malavika Nidhi, Pietro Cicalese, Christopher Gidley, Shobha Dasari, Shree Mohan, Nathan Thai, Van Thi Thanh Truong, Nicole Jordan, Ramesh Saxena, Chaim Putterman, Michelle Petri, Chandra Mohan

doi: 10.1136/annrheumdis-2019-216312
Correspondence
Rheumatic disease and COVID-19
Free

Jean W Liew, Elizabeth R Graef

doi: 10.1136/annrheumdis-2020-217674
Rheumatoid arthritis
Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-γ treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis

Xiao He, Yi Yang, Mengwei Yao, Lei Yang, Luoquan Ao, Xueting Hu, Zhan Li, Xiaofeng Wu, Yan Tan, Wei Xing, Wei Guo, Joseph A Bellanti, Song Guo Zheng, Xiang Xu

doi: 10.1136/annrheumdis-2020-217798

July 09, 2020

Correspondence
Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?
Free

Pedro Santos-Moreno, Diana Buitrago-Garcia, Laura Villarreal, Anggie Aza, Michael Cabrera, Wilberto Rivero, Adriana Rojas-Villarraga

doi: 10.1136/annrheumdis-2020-218259
Autoinflammatory disorders
Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation

Tomoko Matsuda, Naotomo Kambe, Yoko Ueki, Nobuo Kanazawa, Kazushi Izawa, Yoshitaka Honda, Atsushi Kawakami, Syuji Takei, Kyoko Tonomura, Masami Inoue, Hiroko Kobayashi, Ikuo Okafuji, Yoshihiko Sakurai, Naoki Kato, Yuta Maruyama, Yuzaburo Inoue, Yoshikazu Otsubo, Teruhiko Makino, Satoshi Okada, Ichiro Kobayashi, Masato Yashiro, Shusaku Ito, Hiroshi Fujii, Yasuhiro Kondo, Nami Okamoto, Shuichi Ito, Naomi Iwata, Utako Kaneko, Mototsugu Doi, Junichi Hosokawa, Osamu Ohara, Megumu K Saito, Ryuta Nishikomori PIDJ members in the JSIAD

doi: 10.1136/annrheumdis-2020-217320
Letter
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study
Free

Nicola Potere, Marcello Di Nisio, Donatella Cibelli, Rosa Scurti, Antonella Frattari, Ettore Porreca, Antonio Abbate, Giustino Parruti

doi: 10.1136/annrheumdis-2020-218243
Correspondence response
Response to: ‘Emergency arising from patients’ fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?’ by Santos-Mareno et al
Free

Jean W Liew, Elizabeth R Graef, Jeffrey A Sparks, Alfred Hyoungju Kim

doi: 10.1136/annrheumdis-2020-218432

July 06, 2020

Correspondence
COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study
Free

Muserref Kasap Cuceoglu, Ezgi Deniz Batu, Yelda Bilginer, Seza Özen

doi: 10.1136/annrheumdis-2020-218341
Correspondence
Should patients starting biologics be screened for COVID-19?
Free

Jesus Alberto Cardenas-de la Garza, Rosa I Arvizu-Rivera, Dionicio Angel Galarza-Delgado

doi: 10.1136/annrheumdis-2020-218437
Correspondence
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD
Free

Maurizio Benucci, Arianna Damiani, Gianfranco Giannasi, Francesca Li Gobbi, Luca Quartuccio, Valentina Grossi, Maria Infantino, Mariangela Manfredi

doi: 10.1136/annrheumdis-2020-218214
Correspondence response
Response to: ‘Comparative analysis of synovial inflammation after SARS-CoV-2 infection’ by Alivernini et al
Free

María-del-Carmen López-González, Vega Jovani, Esperanza Merino, Paloma Vela, Mariano Andrés

doi: 10.1136/annrheumdis-2020-218368
Correspondence
Comparative analysis of synovial inflammation after SARS-CoV-2 infection
Free

Stefano Alivernini, Antonella Cingolani, Marco Gessi, Annamaria Paglionico, Giuliana Pasciuto, Barbara Tolusso, Massimo Fantoni, Elisa Gremese

doi: 10.1136/annrheumdis-2020-218315
Correspondence response
Response to: ‘COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study’ by Cuceoglu et al
Free

Carlo Salvarani, Gianluigi Bajocchi, Pamela Mancuso, Elena Galli, Francesco Muratore, Paolo Giorgi Rossi

doi: 10.1136/annrheumdis-2020-218364

July 03, 2020

Correspondence
Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still’s disease
Free

Piero Ruscitti, Tanja A Stamm, Roberto Giacomelli

doi: 10.1136/annrheumdis-2020-218032
Epidemiology
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
Free

Emanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Angela Napolitano, Salvatore La Marca, Nicola Boffini, Valentina Da Prat, Gaetano Di Terlizzi, Marco Lanzillotta, Patrizia Rovere Querini, Annalisa Ruggeri, Giovanni Landoni, Moreno Tresoldi, Fabio Ciceri, ALberto Zangrillo, Francesco De Cobelli, Lorenzo Dagna SARI-RAF Study Group

doi: 10.1136/annrheumdis-2020-218122
Correspondence response
Response to: ‘Changing the outcome measures, changing the results? The urgent need of a specific Disease Activity Score to adult-onset Still’s disease’ by Ruscitti et al
Free

Claudia Kedor, Joachim Listing, Jan Zernicke, Eugen Feist

doi: 10.1136/annrheumdis-2020-218143

July 02, 2020

Correspondence response
Response to: ‘Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey’ by Plüß et al
Free

Alexis Mathian, Zahir Amoura

doi: 10.1136/annrheumdis-2020-218069
Correspondence
Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland
Free

Neus Quilis, Paloma Vela, Boris A Blanco Cáceres, Cesar Diaz-Torne, Enrique Calvo-Aranda, Francisca Sivera, Alejandro Prada-Ojeda, Fernando Pérez Ruiz, Eliseo Pascual, Mariano Andrés

doi: 10.1136/annrheumdis-2020-218226
Correspondence response
Response to: ‘Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort’ by Costa et al
Free

Latika Gupta, Durga Prasanna Misra, Vishwesh Agarwal, Suma Balan, Vikas Agarwal

doi: 10.1136/annrheumdis-2020-217953
Correspondence
Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey
Free

Marlene Plüß, Gamal Chehab, Peter Korsten

doi: 10.1136/annrheumdis-2020-217967
Correspondence response
Response to: ‘Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland’ by Quills et al
Free

Jasvinder A Singh

doi: 10.1136/annrheumdis-2020-218263
Correspondence
Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India
Free

Latika Gupta, Durga Prasanna Misra, Vishwesh Agarwal, Suma Balan, Vikas Agarwal

doi: 10.1136/annrheumdis-2020-217509

July 01, 2020

Correspondence response
Evaluating diagnostic criteria for macrophage activation syndrome in patients with adult onset Still’s disease. Response to: ‘Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease associated macrophage activation syndrome’ by Zhang et al
Free

Francesca Minoia, Angelo Ravelli

doi: 10.1136/annrheumdis-2020-218033
Correspondence
Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease-associated macrophage activation syndrome
Free

Lei Zhang, Xiaopei Yang, Tian-Fang Li, Xiaojun Liu, Shengyun Liu

doi: 10.1136/annrheumdis-2020-217917
Views on news
Methotrexate: what are the true risks of treatment?

Anja Strangfeld, Gerd R Burmester

doi: 10.1136/annrheumdis-2020-217207
Letter
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics
Free

Arielle Mendel, Sasha Bernatsky, Anca Askanase, Sang-Cheol Bae, Ann Elaine Clarke, Nathalie Costedoat-Chalumeau, Dafna D Gladman, Caroline Gordon, John Hanly, Søren Jacobsen, Ken Kalunian, Anselm Mak, Marta Mosca, Bernardo A Pons-Estel, Guillermo Ruiz-Irastorza, Murray Urowitz, Évelyne Vinet

doi: 10.1136/annrheumdis-2020-218164
Correspondence
COVID-19 and the practice of rheumatology in Africa: big changes to services from the shockwave of a pandemic
Free

Richard Oluyinka Akintayo, Akpabio Akpabio, Asgar Kalla, Dzifa Dey, Angela Migowa, Hakeem Olaosebikan, Rachid Bahiri, Yasser El Miedany, Djohra Hadef, Wafa Hamdi, Omondi Oyoo, Samy Slimani, Abubakar Yerima, Yassmin Taha, Adewale Adebajo, Olufemi Adelowo, Mohammed Tikly, Imad Ghozlani, Kawther Ben Abdelghani, Nermeen Ahmed Fouad, Doaa Mosad, Dalia El Mikkawy, Mohamed Hassan Abu-Zaid, Rasha A Abdel-Magied

doi: 10.1136/annrheumdis-2020-218273

June 30, 2020

Epidemiology
Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group

Sabrina Mai Nielsen, Helene Storgaard, Torkell Ellingsen, Beverley J Shea, George A Wells, Vivian Andrea Welch, Daniel E Furst, Maarten de Wit, Marieke Voshaar, Carsten Bogh Juhl, Maarten Boers, Reuben Escorpizo, Thasia G Woodworth, Annelies Boonen, Henning Bliddal, Lyn M March, Peter Tugwell, Robin Christensen

doi: 10.1136/annrheumdis-2020-217237
Letter
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases

Laura Nuño, Marta Novella Navarro, Gema Bonilla, Karen Franco-Gómez, Pilar Aguado, Diana Peiteado, Irene Monjo, Carolina Tornero, Alejandro Villalba, Maria-Eugenia Miranda-Carus, Eugenio De Miguel, Patricia Bogas, Ana Castilla-Plaza, Miguel Bernad-Pineda, Elena García-Lorenzo, Tamara Rodríguez-Araya, Alejandro Balsa

doi: 10.1136/annrheumdis-2020-218054
Correspondence response
Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al
Free

Milena Gianfrancesco, Kimme L Hyrich, Jinoos Yazdany, Pedro M Machado, Philip C Robinson

doi: 10.1136/annrheumdis-2020-218328
Systemic sclerosis
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT

Mariaelena Occhipinti, Cosimo Bruni, Gianna Camiciottoli, Maurizio Bartolucci, Silvia Bellando-Randone, Anna Bassetto, Giovanna Cuomo, Dilia Giuggioli, Giulia Ciardi, Alessio Fabbrizzi, Sara Tomassetti, Federico Lavorini, Massimo Pistolesi, Stefano Colagrande, Marco Matucci-Cerinic

doi: 10.1136/annrheumdis-2020-217359
Correspondence
Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis
Free

Andrea Hermina Györfi, Markus Kopp, Matthias May, Marcel Vetter, Michael Uder, Andreas E Kremer, Georg Schett, Thomas Harrer, Jörg H W Distler

doi: 10.1136/annrheumdis-2020-218258

June 26, 2020

Correspondence response
Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: ‘Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab’ by Schulze-Koops et al
Free

Sara Monti, Carlomaurizio Montecucco

doi: 10.1136/annrheumdis-2020-218148
Paediatric rheumatology
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort
Free

Marie Pouletty, Charlotte Borocco, Naim Ouldali, Marion Caseris, Romain Basmaci, Noémie Lachaume, Philippe Bensaid, Samia Pichard, Hanane Kouider, Guillaume Morelle, Irina Craiu, Corinne Pondarre, Anna Deho, Arielle Maroni, Mehdi Oualha, Zahir Amoura, Julien Haroche, Juliette Chommeloux, Fanny Bajolle, Constance Beyler, Stéphane Bonacorsi, Guislaine Carcelain, Isabelle Koné-Paut, Brigitte Bader-Meunier, Albert Faye, Ulrich Meinzer, Caroline Galeotti, Isabelle Melki

doi: 10.1136/annrheumdis-2020-217960
Letter
Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Ruth E Costello, Jenny H Humphreys, Kevin L Winthrop, William G Dixon

doi: 10.1136/annrheumdis-2020-217255
Correspondence
Eosinophilic granulomatosis with polyangiitis can manifest lacrimal and salivary glands swelling by granulomatous inflammation: a potential mimicker of IgG4-related disease
Free

Mitsuhiro Akiyama, Yuko Kaneko, Tsutomu Takeuchi

doi: 10.1136/annrheumdis-2020-218124
Correspondence
Case of acute arthritis following SARS-CoV-2 infection
Free

Naoto Yokogawa, Naoto Minematsu, Harutaka Katano, Tadaki Suzuki

doi: 10.1136/annrheumdis-2020-218281
Correspondence
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
Free

Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht, Rebecca Hasseli, Alla Skapenko

doi: 10.1136/annrheumdis-2020-218075
Epidemiology
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
Free

Jose L Pablos, Lydia Abasolo, Jose M Alvaro-Gracia, Francisco J Blanco, Ricardo Blanco, Isabel Castrejón, David Fernandez-Fernandez, Benjamín Fernandez-Gutierrez, María Galindo-Izquierdo, Miguel A Gonzalez-Gay, Sara Manrique-Arija, Natalia Mena Vázquez, Antonio Mera Varela, Miriam Retuerto, Alvaro Seijas-Lopez RIER investigators group

doi: 10.1136/annrheumdis-2020-217763
Correspondence response
Response to: ‘Eosinophilic granulomatosis with polyangiitis can manifest lacrimal and salivary glands swelling by granulomatous inflammation: a potential mimicker of IgG4-related disease’ by Akiyama et al
Free

Augusto Vaglio, Federica Maritati, Jochen Zwerina

doi: 10.1136/annrheumdis-2020-218174

June 25, 2020

Correspondence
Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences
Free

Jun Zhao, Rongrong Pang, Jian Wu, Yanju Guo, Yang Yang, Libo Zhang, Xinyi Xia

doi: 10.1136/annrheumdis-2020-218183
Correspondence response
Response to: ‘COVID-19 in patients with rheumatological diseases treated with Anti-TNF’ by Brito et al and ‘Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences’ by Zhao et al
Free

Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Hsu, Jeffrey A Sparks, Zachary Scott Wallace

doi: 10.1136/annrheumdis-2020-218196
Correspondence response
Is a human in vitro enthesitis model relevant to SpA-associated enthesitis? Response to: ‘Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease’ by Alunno et al
Free

Abdulla Watad, Hannah Rowe, Darren Newton, Charlie Bridgewood, Dennis G McGonagle

doi: 10.1136/annrheumdis-2020-218151
Correspondence
Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors
Free

Vega Jovani, Irene Calabuig, Maria Luisa Peral-Garrido, Ernesto Tovar-Sugrañes, María-del-Carmen López-González, Pilar Bernabeu, Agustín Martínez, Joaquim Esteve-Vives, Jose-Manuel León-Ramírez, Oscar Moreno-Perez, Vicente Boix, Joan Gil, Esperanza Merino, Paloma Vela, Mariano Andrés

doi: 10.1136/annrheumdis-2020-218152
Correspondence
Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
Free

Zoé Gendebien, Christian von Frenckell, Clio Ribbens, Béatrice André, Marie Thys, Marjorie Gangolf, Laurence Seidel, Michel G Malaise, Olivier Malaise

doi: 10.1136/annrheumdis-2020-218244
Correspondence response
Response to: ‘Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors’ by Jovani et al
Free

Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Hsu, Jeffrey A Sparks, Zachary S Wallace

doi: 10.1136/annrheumdis-2020-218179
Correspondence
Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic
Free

Pedro Santos-Moreno, Josefina Chavez-Chavez, Sandra Milena Hernández-Zambrano, Diana Patricia Rivera-Triana, Ruth Alexandra Castiblanco-Montañez, Anggie Aza, Diana Buitrago-Garcia, Laura Villarreal, Adriana Rojas-Villarraga

doi: 10.1136/annrheumdis-2020-218165

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

July 10, 2020

July 09, 2020

July 06, 2020

July 03, 2020

July 02, 2020

July 01, 2020

June 30, 2020

June 26, 2020

June 25, 2020

Pages